ConductScience.org, home

Paper3758143

Evaluation of once daily endralazine in hypertension.

Wu R and 2 others. Eur J Clin Pharmacol, 1986. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of once daily endralazine in hypertension. Papers, record 3758143. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3758143

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of once daily endralazine in hypertension.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2019-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu RR
2Spence JDJ D
3Carruthers SGS G

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
HypertensionMajor topic
PyridazinesMajor topic
Acetylation
Adult
Aged
Blood Pressure
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17298742Sensitive high-performance liquid chromatographic assay for endralazine and two of its metabolites in human plasma.J Chromatogr1981https://conductscience.org/library/papers/7298742PubMed
26882620The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6882620PubMed
3857459[Hemodynamic study on a new antihypertensive drug (a pyridopyridazine) in the treatment of hypertensive crisis and resistent hypertension. First findings in man (author's transl)].Z Kardiol1977https://conductscience.org/library/papers/857459PubMed
43918712Hydralazine induced lupus syndrome with eye disease.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3918712PubMed
526870[Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)].MMW Munch Med Wochenschr1978https://conductscience.org/library/papers/26870PubMed
67050561Hydralazine and related compounds: chemistry, metabolism, and mode of action.Med Res Rev1981https://conductscience.org/library/papers/7050561PubMed
76132036Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.Lancet1983https://conductscience.org/library/papers/6132036PubMed
87343274[Management of treatment-resistant hypertension: comparison of the antihypertensive effect of endralazine and minoxidil (author's transl)].Dtsch Med Wochenschr1981https://conductscience.org/library/papers/7343274PubMed
96181329Endralazine, a new peripheral vasodilator--a randomized cross-over trial against dihydralazine.J Cardiovasc Pharmacol1982https://conductscience.org/library/papers/6181329PubMed
10232662[Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)].Arzneimittelforschung1979https://conductscience.org/library/papers/232662PubMed
11546422[Bicyclic 3-hydrazinopyridazines with antihypertensive action (author's transl)].Arzneimittelforschung1979https://conductscience.org/library/papers/546422PubMed
1255060Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators.Acta Med Scand1975https://conductscience.org/library/papers/55060PubMed
137259927Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7259927PubMed
147296843Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status.Clin Chem1981https://conductscience.org/library/papers/7296843PubMed
156984902Endralazine in patients with severe hypertension and renal insufficiency.Postgrad Med J1982https://conductscience.org/library/papers/6984902PubMed
1692167Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.Acta Med Scand1979https://conductscience.org/library/papers/92167PubMed
177471604Effect of dose on acetylator phenotype distribution of hydralazine.Clin Pharmacol Ther1981https://conductscience.org/library/papers/7471604PubMed
186749347Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension.Clin Exp Hypertens A1982https://conductscience.org/library/papers/6749347PubMed
196364562[Experience with endralazine in the treatment of essential hypertension].Vnitr Lek1984https://conductscience.org/library/papers/6364562PubMed
206974555Relationship between immune response to hydralazine and to deoxyribonuclease in patients receiving hydralazine.Arthritis Rheum1981https://conductscience.org/library/papers/6974555PubMed

See all 30 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
3609114Effect of food intake on plasma levels and antihypertensive response during maintenance therapy with endralazine.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3609114

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3758143

GET https://conductscience.org/api/papers/v1/3758143/references?page=2